RBC Bioscience Corporation (6848.TWO)
TWD 18.05
(0.28%)
TWD 18.05
(0.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 422.18 Million TWD | -1.48% |
| 2022 | 428.52 Million TWD | -4.62% |
| 2021 | 449.26 Million TWD | 360.37% |
| 2020 | 97.58 Million TWD | 406.48% |
| 2019 | 19.26 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 383.68 Million TWD | 0.12% |
| 2024 Q1 | 383.77 Million TWD | -9.1% |
| 2023 Q2 | 423.16 Million TWD | 4.42% |
| 2023 Q4 | 422.18 Million TWD | 4.13% |
| 2023 FY | 422.18 Million TWD | -1.48% |
| 2023 Q1 | 405.27 Million TWD | -5.43% |
| 2023 Q3 | 405.44 Million TWD | -4.19% |
| 2022 Q3 | 404.05 Million TWD | 0.0% |
| 2022 FY | 428.52 Million TWD | -4.62% |
| 2022 Q4 | 428.52 Million TWD | 6.06% |
| 2021 FY | 449.26 Million TWD | 360.37% |
| 2020 FY | 97.58 Million TWD | 406.48% |
| 2019 FY | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 259.816% |
| Level Biotechnology Inc. | -453.9 Million TWD | 193.012% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 450.158% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 314.965% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 15.537% |
| GlycoNex Incorporation | -148.56 Million TWD | 384.171% |
| VBI | -25.31 Million TWD | 1767.661% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | -948.49% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | -205.942% |
| Visgeneer Inc. | 31.28 Million TWD | -1249.524% |
| Mycenax Biotech Inc. | 207 Million TWD | -103.945% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 162.031% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 414.472% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 32.074% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 832.223% |
| Enimmune corporation | -314.15 Million TWD | 234.386% |
| TaiRx, Inc. | -147.86 Million TWD | 385.513% |
| CHO Pharma, Inc. | -203.79 Million TWD | 307.165% |
| EirGenix Inc. | -4.58 Billion TWD | 109.202% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 598.077% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | -249.286% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 113.119% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 233.006% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 2230.848% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | -1227.25% |
| Lukas Biomedical Inc. | 50.75 Million TWD | -731.81% |
| BiOptic Inc. | 12.59 Million TWD | -3252.803% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 144.704% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 516.003% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 355.597% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | -34.081% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 647.979% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 260.782% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -1280.682% |
| Neith Corporation | -150.31 Million TWD | 380.874% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 756.372% |
| NaviFUS Corp. | -123.12 Million TWD | 442.88% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -470.127% |
| Sinew Pharma Inc. | -160.34 Million TWD | 363.298% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 274.534% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 225.139% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 202.314% |
| AP Biosciences Inc | -196.52 Million TWD | 314.822% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 38.701% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 3791.396% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 150.885% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 68.896% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 201.761% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 301.676% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 393.463% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 227.725% |
| TCI GENE Inc. | -689.25 Million TWD | 161.253% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 454.962% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 132.247% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -1961.148% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 514.435% |
| PharmaEngine, Inc. | -860.8 Million TWD | 149.045% |
| Savior Lifetec Corporation | -812.54 Million TWD | 151.958% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 240.743% |
| OBI Pharma, Inc. | -398.22 Million TWD | 206.017% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 215.534% |
| Acepodia, Inc. | -6.02 Billion TWD | 107.013% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 112.411% |